Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:40 PM
Ignite Modification Date:
2025-12-24 @ 7:40 PM
NCT ID:
NCT06920303
Eligibility Criteria:
Inclusion Criteria:
* patients who have acute ischemic strokes or transient ischemic attacks .
Exclusion Criteria:
1. Patients with history of cardiac arrhythmia or discovered recently or known rheumatic heart disease.
2. Patients with history of autoimmune diseases.
3. Patients with space occupying lesion or hemorrhage in Ct brain.
4. Pregnant female.
5. Patients who refuse to participate in the study.
6. Patients who have history of allergy or developed acute kidney injury during previous dye injection.
7. Patients who have chronic kidney disease.
8. Premorbid neurological disorder (myopathy, multiple sclerosis) on neurological examination or previous investigations.
9. Inability to achieve safe vascular access.
10. Patients with insufficient temporal acoustic window.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT06920303
Study Brief:
Protocol Section:
NCT06920303